X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf
https://www.globenewswire.com/news-release/2023/12/06/2791835/0/en/Scilex-Holding-Company-announces-that-ZTlido-lidocaine-topical-system-will-be-added-as-a-preferred-agent-to-the-Medicaid-Preferred-Drug-List-PDL-in-two-new-states-one-Midwestern-an.html
https://www.globenewswire.com//news-release/2023/12/04/2790087/0/en/Scilex-Holding-Company-announces-the-addition-of-ZTlido-lidocaine-topical-system-as-a-preferred-agent-to-the-Medicaid-Preferred-Drug-List-PDL-of-the-State-of-Tennessee.html
https://www.globenewswire.com//news-release/2023/11/15/2781106/0/en/Scilex-Holding-Company-Announces-Issuance-of-New-Patent-in-the-U-S-for-Its-Lead-Commercial-Product-ZTlido-lidocaine-topical-system-for-a-Method-of-Relieving-Pain-Through-the-Applic.html
https://www.globenewswire.com//news-release/2023/11/02/2772364/0/en/Scilex-Holding-Company-Announces-New-Data-From-Deeper-Skin-Penetration-Studies-to-Support-SP-103-lidocaine-topical-system-5-4-a-Triple-Strength-Formulation-of-ZTlido-in-Treatment-o.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-25-2023-66768.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-11-2023-46012.pdf
https://www.globenewswire.com//news-release/2023/09/14/2743321/0/en/Scilex-Holding-Company-Announces-the-Completion-of-its-SP-103-lidocaine-topical-system-5-4-Triple-Strength-Formulation-of-ZTlido-Phase-2-trial-which-achieved-its-objectives-to-Eval.html
https://www.globenewswire.com//news-release/2023/09/12/2741736/0/en/Scilex-Holding-Company-Presented-Oral-and-Poster-Presentations-on-ZTlido-lidocaine-topical-system-at-the-2023-Annual-PAINWeek-Conference-Held-in-Las-Vegas-NV.html
https://finance.yahoo.com/news/pfizer-says-supply-drugs-may-205442629.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-10-2023-12326.pdf
https://www.globenewswire.com/news-release/2023/05/04/2661612/0/en/Scilex-Holding-Company-Announces-Complete-Enrollment-of-a-Phase-2-Study-to-Evaluate-the-Safety-and-Efficacy-of-SP-103-lidocaine-topical-system-5-4-Triple-Strength-Formulation-of-ZT.html
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://www.globenewswire.com/news-release/2022/08/16/2499169/0/en/Scilex-Holding-Company-a-Sorrento-Company-Announces-Expanding-Coverage-to-30-Million-Lives-And-Will-Continue-To-Work-To-Access-An-Additional-20-Million-Lives-With-One-Of-The-Larges.html
https://www.fiercepharma.com/pharma/spac-merger-looming-scilex-sues-apotex-block-generic-copy-key-pain-patch
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-lidocaine-1652172266.pdf
https://www.expresspharma.in/aleor-dermaceuticals-receives-us-fda-final-approval-for-lidocaine-and-prilocaine-cream/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213923
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-30-2022-1648618596.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216250
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-2-2022-1643778781.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-8-2021-1631096882.pdf
https://www.globenewswire.com/news-release/2021/08/19/2283614/0/en/Scilex-Holding-Company-a-Sorrento-Therapeutics-Inc-Subsidiary-Announces-Expansion-of-Ztlido-Managed-Care-Coverage-for-Additional-33-Million-Lives.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-21-2021-1619072775.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-17-2021-1613546616.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213253
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206463
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-19-2020-1597808962.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-3-2020-1591161308.pdf
https://www.hhs.gov/about/news/2020/05/19/hhs-industry-partners-expand-us-based-pharmaceutical-manufacturing-covid-19-response.html
https://www.nationalacademies.org/news/2020/05/there-is-a-lack-of-evidence-transparency-about-ingredients-to-support-use-of-compounded-topical-pain-creams-says-new-report
https://www.businesswire.com/news/home/20191029005235/en/Vapogenix-Reports-Encouraging-Phase-II-Results-Topical
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212486
https://www.biospace.com/article/releases/premier-s-providegx-program-partners-with-amphastar-to-provide-seven-shortage-drugs-most-in-emergency-pre-filled-syringes-/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-25-2019-1569469631.pdf
http://www.pharmatimes.com/news/xospata_leads_latest_chmp_recommendations_1302120
https://www.raps.org/news-and-articles/news-articles/2019/9/emas-chmp-recommends-three-new-medicines
https://www.pharmacompass.com/pdf/news/KRS-Global-Biotechnology-Issues-Voluntary-Nationwide-Recall-of-All-Human-and-Animal-Sterile-Drug-Products-1568424609.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://www.pharmacompass.com/pdf/news/ridge-properties-llc-dba-pain-relief-naturally-issues-voluntary-nationwide-recall-of-pre-tat-1565422024.pdf
https://www.pharmacompass.com/pdf/news/snugz-usa-inc-receives-fda-warning-letter-1562734408.pdf
https://www.pharmacompass.com/pdf/news/snugz-usa-inc-receives-fda-warning-letter-1562148572.pdf
https://www.pharmacompass.com/pdf/news/Premier-Pharmacy-Labs-Issues-Voluntary-Nationwide-Recall-of-all-Unexpired-Sterile-Drug-Product-Lots-Due-to-Lack-of-Sterility-Assurance-1560923636.pdf
https://www.prnewswire.com/news-releases/aratana-therapeutics-granted-fda-approval-of-nocita-bupivacaine-liposome-injectable-suspension-10-ml-vial-300865670.html
https://www.pharmacompass.com/pdf/news/advanced-botanical-consulting-testing-inc-dba-abc-testing-receives-fda-warning-letter-1560416930.pdf
Market Place
Share 
